End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3.78 PHP | +2.72% | +13.17% | -13.70% |
04-24 | Acen Corporation Announces Board and Committee Changes | CI |
04-24 | Acen Corporation Announces Election of Directors | CI |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- The group's activity appears highly profitable thanks to its outperforming net margins.
- The company appears to be poorly valued given its net asset value.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
- The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
- Based on current prices, the company has particularly high valuation levels.
- For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Independent Power Producers
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-13.70% | 2.6B | B- | ||
+14.41% | 41.39B | B | ||
+12.65% | 27.36B | - | C | |
+17.68% | 15.95B | B- | ||
+25.58% | 12.07B | B | ||
+21.90% | 8.9B | C+ | ||
+22.76% | 6.41B | C+ | ||
+56.88% | 5.9B | D- | ||
+33.57% | 5.08B | C | ||
-1.01% | 4.17B | - | C |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
- Stock Market
- Equities
- ACEN Stock
- Ratings Acen Corporation